SCHEMBL98194

SCHEMBL98194

CC(C)(C)C(=O)CC(=O)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
OR51E2 Q9H255 2/20 0.38
HAO1 Q9UJM8 3/20 0.38
KMT2A Q03164 1/20 0.38
FEN1 P39748 6/20 0.36
ERCC5 P28715 5/20 0.36
PTPN1 P18031 2/20 0.36
MAPK1 P28482 1/20 0.35
SLC13A3 Q8WWT9 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35
HSD11B1 P28845 1/20 0.34
TSHR P16473 2/20 0.33
HMGCR P04035 1/20 0.33
CHRM1 P11229 1/20 0.33
TBXA2R P21731 1/20 0.33
ADRA1A P35348 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29695621 0.84 KMT2A (0.37) OR51E2KMT2AMAPK1HSD11B1TSHR
SCHEMBL31154196 0.84 KMT2A (0.37) OR51E2KMT2AMAPK1HSD11B1TSHR
SCHEMBL93393 0.81 KMT2A (0.39) KMT2AMAPK1HSD11B1TSHRHMGCR
SCHEMBL4837194 0.81 KMT2A (0.39) KMT2AMAPK1HSD11B1TSHRHMGCR
SCHEMBL954279 0.79 LDHA (0.47) KMT2AEGLN1HSD11B1TSHRHMGCR
SCHEMBL24013363 0.78 KMT2A (0.33) KMT2A
SCHEMBL9566006 0.78 KMT2A (0.37) KMT2AMAPK1HSD11B1TSHRHMGCR
SCHEMBL21405194 0.78 KMT2A (0.37) KMT2AMAPK1HSD11B1TSHRHMGCR
SCHEMBL21002308 0.78 KMT2A (0.37) KMT2AMAPK1HSD11B1TSHRHMGCR
SCHEMBL15788938 0.78 KMT2A (0.37) KMT2AMAPK1HSD11B1TSHRHMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3156456-B1 ONE-PART ADDITION-CURING HEAT-CONDUCTIVE SILICONE GREASE COMPOSITION SHINETSU CHEMICAL CO (JP) 2021-01-20 EP claimed
EP-3199591-B1 UV-THICKENING THERMALLY CONDUCTIVE SILICONE GREASE COMPOSITION SHINETSU CHEMICAL CO (JP) 2020-04-29 EP claimed
EP-0693473-B1 Method of producing pivaloylacetic acid ester UBE INDUSTRIES (JP) 1998-04-22 EP claimed
US-5679830-A DECARBONYLATION OF PIVALOYLPYRUVIC ACID IN THE PRESENCE OF AN INORGANIC OXIDE CATALYST UBE INDUSTRIES, LTD. (JP) 1997-10-21 US claimed
EP-0693473-A1 Method of producing pivaloylacetic acid ester UBE INDUSTRIES, LTD. (JP) 1996-01-24 EP claimed
US-5449799-A Compound for depositing copper layers TERFLOTH CHRISTIAN (DE) 1995-09-12 US claimed
EP-0454843-A4 METHOD AND APPARATUS FOR THE RAPID DEPOSITION BY CHEMICAL VAPOR DEPOSITION WITH LOW VAPOR PRESSURE REACTANTS GEORGIA TECH RES INST (US) 1994-12-28 EP claimed
EP-0454843-A1 METHOD AND APPARATUS FOR THE RAPID DEPOSITION BY CHEMICAL VAPOR DEPOSITION WITH LOW VAPOR PRESSURE REACTANTS GEORGIA TECH RESEARCH CORPORATION (US) 1991-11-06 EP claimed
WO-1991007236-A1 METHOD AND APPARATUS FOR THE RAPID DEPOSITION BY CHEMICAL VAPOR DEPOSITION WITH LOW VAPOR PRESSURE REACTANTS GEORGIA TECH RESEARCH CORPORATION (US) 1991-05-30 WO claimed
EP-0028758-B1 PROCESS FOR PREPARING ALKYL ESTERS AND CYCLOALKYL ESTERS OF PIVALOYL-PYRUVIC ACID BAYER AG (DE) 1982-12-15 EP claimed
US-9828379-B2 Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof ABIDE THERAPEUTICS, INC. (US) 2017-11-28 US disclosed
US-20160137649-A1 PYRROLO-PYRROLE CARBAMATE AND RELATED ORGANIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF ABIDE THERAPEUTICS, INC. 2016-05-19 US disclosed
EP-3016653-A1 PYRROLO-PYRROLE CARBAMATE AND RELATED ORGANIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF Abide Therapeutics, Inc. (US) 2016-05-11 EP disclosed
US-9035446-B2 Power module FUJI ELECTRIC CO., LTD. (JP) 2015-05-19 US disclosed
WO-2015003002-A1 PYRROLO-PYRROLE CARBAMATE AND RELATED ORGANIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF ABIDE THERAPEUTICS, INC. (US) 2015-01-08 WO disclosed
EP-0693473-B1 Method of producing pivaloylacetic acid ester UBE INDUSTRIES (JP) 1998-04-22 EP disclosed
US-5679830-A DECARBONYLATION OF PIVALOYLPYRUVIC ACID IN THE PRESENCE OF AN INORGANIC OXIDE CATALYST UBE INDUSTRIES, LTD. (JP) 1997-10-21 US disclosed
EP-0693473-A1 Method of producing pivaloylacetic acid ester UBE INDUSTRIES, LTD. (JP) 1996-01-24 EP disclosed
US-5449799-A Compound for depositing copper layers TERFLOTH CHRISTIAN (DE) 1995-09-12 US disclosed
EP-0028758-A1 Process for preparing alkyl esters and cycloalkyl esters of pivaloyl-pyruvic acid BAYER AG (DE) 1981-05-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160137649-A1 PYRROLO-PYRROLE CARBAMATE AND RELATED ORGANIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF FAAH, FAAH2, ABHD6 OR51E2 1159/4885HAO1 2946/4885KMT2A 2502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.